Abstract:The optimal management for pregnant women with cancer should be selected by the medical team (Ob/Gyn/perinatologist, neonatologist, oncologist), the patient and her family, depending on the gestational age, type and stage of cancer, therapeutic options and the patient's wishes. If the malignancy is not progressing, pregnancy should be continued as long as possible for the child to obtain adequate birthweight. Both surgery and chemotherapy were safe therapeutic choices, as most pregnancies continued successfully after therapy. Introduction Cancer complicating pregnancy is a rare but potentially life‐threatening condition for both the mother and her child. The aim of the present study was to assess the outcomes for mothers and children after pregnancy complicated by malignancy and to investigate which parameters are important for their 1‐year survival. Material and methods The study included 84 pregnant women diagnosed with malignant tumors during pregnancy from 2001 to 2022. The pregnancy course and outcome, as well as parameters that could influence the survival and condition of the mother and child were evaluated. Mothers and children were followed up for 1 year after delivery to assess their condition/complications and overall survival. Results Most malignancies were gynecological (31%) or hematological (23.8%) and were diagnosed and surgically treated in the second trimester. Most children (69%) showed adequate growth and development throughout pregnancy but were delivered before term (53.6%) to allow mothers to receive therapy. Adjuvant therapy during pregnancy mostly caused a transitory deterioration of the child's condition, while surgery did not significantly impact the pregnancy course. Deliveries, on average, occurred during the 33.01 ± 6.16 gestational week (range: 20–40) and mostly by cesarean section (76.2%). For mothers, the pregnancy survival rate was 95.2% and survival after 1 year was 87.5%. However, 37.5% of women were still ill and required additional therapy 1 year postpartum. The pregnancy survival rate for children was 94%, whereas the 1‐year survival rate was 76.2%. Most children had a favorable condition (alive, adequately growing and developing, and without complications) at birth (81%) as well as at the 1‐year follow‐up (63.7%). Regression analysis identified the following predictors of favorable 1‐year maternal condition: applying therapy during pregnancy, no progression of the malignancy during pregnancy, and delivery at a later gestational week. Predictors of favorable 1‐year condition of children were lower histopathological grade of malignancy, surgery as therapy for malignancy, obtaining higher birthweight, and delivery by cesarean section. Conclusions If the malignancy is not progressing, pregnancy should be continued as long as possible for the child to obtain adequate birthweight. Both surgery and chemotherapy were safe therapeutic choices, as most pregnancies continued successfully after therapy.

[Iatrogeny and the elderly].

Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice.

What Influences the Long-Term Survival of Advanced High-Grade Serous Ovarian Cancer?

Clinicopathological Characteristics and Treatment Outcomes of Pregnancy Complicated by Malignant Ovarian Germ Cell Tumors.

Glioma in the third trimester of pregnancy: Two cases and a review of the literature

P11.22.B ANALYSIS OF FACTORS RELATED TO POSTOPERATIVE RECURRENCE AND PROGNOSIS ABOUT HIGH GRADE SPINAL CORD GLIOMAS

Relationship between the extent of resection and the survival of patients with low-grade gliomas: a systematic review and meta-analysis

Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project

Ctni-65. Determinants Of Long-Term Survival In Patients With Idh-Mutant Gliomas

Cancer during pregnancy: Twenty‐two years of experience from a tertiary referral center

Long-term survivors in 976 supratentorial glioblastoma, IDH-wildtype patients

Efficacy of Surgery and Further Treatment of Progressive Glioblastoma

Predictors of tumor progression of low-grade glioma in adult patients within 5 years follow-up after surgery

Long-term impact of adult WHO grade II or III gliomas on health-related quality of life: A systematic review

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas

Epid-28. Trends In Low Grade Glioma Prognosis And The Evolving Impact Of Gross Total Resection Across Fifty Years: A Multicohort Analysis

A multivariate retrospective analysis of high-grade gliomas: Survival and prognostic factors

1238 Next Generation Sequencing of Gliomas to Identify Predictors of Time to Postoperative Epilepsy

Elucidating the clinical-pathological factors and prognosis in breast cancer young surviving women who had a subsequent pregnant

Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma

Predicting factors of tumor progression in adult patients with low-grade glioma within five years after surgery